Table 2_Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats.xlsx by Evan Fuini (21224939)

“…We hypothesized that psilocybin would show a dose-dependent increase in activity in the prefrontal cortex and thalamus, while decreasing hippocampal activity. …”

Table 3_Dose-dependent changes in global brain activity and functional connectivity following exposure to psilocybin: a BOLD MRI study in awake rats.xlsx by Evan Fuini (21224939)

“…We hypothesized that psilocybin would show a dose-dependent increase in activity in the prefrontal cortex and thalamus, while decreasing hippocampal activity. …”

Image 1_A comprehensive analysis of vitamin a deficiency burden and trends: insights from the global burden of disease study 2021 and future predictions to 2050.pdf by Qianhong Hu (22640267)

“…Background<p>Vitamin A deficiency (VAD) continues to pose a significant public health challenge, particularly in low socio-demographic index (SDI) regions, contributing to increased infections, blindness, and child mortality. …”

Demographic information of participants. by Zixia Bu (21475019)

“…The longitudinal results showed a decreasing trend of negative correlation between AB and PA under T1-T3 stages (r = −0.29, r = −0.44, P < 0.01), and no significant change in the degree of negative correlation with HSK (r = −0.28, r = −0.35, P < 0.01). …”

A) Calcium carbonate crystal size versus ferric ion concentration; B) SEM image at ferric ion concentration of 0.03 M; C) Ferric hydroxide colloid. by Jin Zhu (164147)

Baseline characteristics and oxidative profiling. by Summan Thahiem (20988319)

Health inequalities in the burden of IBD among WCBA. by Jiefeng Zhao (9090305)

The global changes of AS prevalence, DALYs, and mortality rates of IBD among women from 1990 to 2021. by Jiefeng Zhao (9090305)

Frontier analysis for the potential for improvement in reducing the burden of IBD among WCBA across 204 countries and regions. by Jiefeng Zhao (9090305)

The expression profile of lipogenic genes, oxidative stress mediators as well as UPR^ER and mitochondrial stress markers. by Summan Thahiem (20988319)

Effect of Viscosol on upstream mediators of inflammasomes activation, PTP1B and inflammasome complexes. by Summan Thahiem (20988319)

Effect of Viscosol on the expression of inflammatory cytokines, chemokines as well as cell death pathways. by Summan Thahiem (20988319)

“…The results shown are represented as mean ±  SD. Significant differences compared to control (****<i>p</i> < 0.0001, ***<i>p</i> < 0.0001, **<i>p</i> < 0.01 and * <i>p</i> <  0.05; two-wayANOVA and Tukey’s test).…”

Agreement between microscopy and qPCR analysis of MarBTN progression. by Rachael M. Giersch (22331947)

Detection of MarBTN-specific eDNA in tank water at late stages of MarBTN progression. by Rachael M. Giersch (22331947)

MarBTN-specific eDNA detection in each clam that was followed for MarBTN in hemolymph and eDNA. by Rachael M. Giersch (22331947)

RNA-sequencing data screening for miR-1247-3p target genes. by Dequan Wang (6007007)

Modeling the relationship between cancer level in hemolymph and MarBTN in tank eDNA. by Rachael M. Giersch (22331947)

Survival of soft-shell clams with MarBTN compared to control clams. by Rachael M. Giersch (22331947)

“…(<i>B</i>) Analysis of long-term non-progressing clams (n = 11, light red line), along with their respective paired controls (blue line), shows no difference in survival with maintained low-level infection. (C) A sub-analysis of low-positive clams in which MarBTN progressed and did not regress (n = 9, dark red line), with survival starting at the time the clam was detected with >10% cancer, compared with their paired control clams starting at the same date (blue line), shows a significant decrease in time-to death. “+” marks the dates at which two negative control animals were culled before natural death (these events were censored in the survival analysis).…”

Mod is required to maintain nucleolar architecture. by Amalia S. Parra (4173004)

Development of <i>Drosophila</i> Neuroblasts (NB). by Amalia S. Parra (4173004)